Abliva AB (publ)
NEVPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | 341.9% | -79.5% | – |
| Gross Profit | – | -$0 | -$0 | -$0 |
| % Margin | – | -50,132.8% | -273,887.1% | -21,429.1% |
| EBITDA | – | -$0 | -$0 | -$0 |
| % Margin | – | -68,327% | -257,709.7% | -80,014.6% |
| Net Income | – | -$0 | -$0 | -$0 |
| % Margin | – | -69,714.6% | -274,077.4% | -81,786.8% |
| EPS Diluted | – | -0.09 | -0.11 | -0.33 |
| % Growth | – | 17.8% | 66.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |